Chemical modification of rapamycin: the discovery of SDZ RAD. - Suppr | 超能文献

相似文献

1

Chemical modification of rapamycin: the discovery of SDZ RAD.

Transplant Proc. 1998 Aug;30(5):2192-4. doi: 10.1016/s0041-1345(98)00587-9.

2

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.新型雷帕霉素衍生物SDZ RAD：体内外药理学特性

Transplantation. 1997 Jul 15;64(1):36-42. doi: 10.1097/00007890-199707150-00008.

3

Comparison of effects of sirolimus on cytokine dependent and cytokine independent proliferation.

Inflamm Res. 1995 Aug;44 Suppl 2:S189-90. doi: 10.1007/BF01778325.

4

Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand.基于雷帕霉素的高亲和力结合FKBP12配体的设计与合成。

Chem Biol. 1995 Mar;2(3):157-61. doi: 10.1016/1074-5521(95)90070-5.

5

Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.环孢素A、FK506和雷帕霉素：与亲免素的结合及生物学作用。

Chem Immunol. 1994;59:128-55.

6

27-O-demethylrapamycin, an immunosuppressant compound produced by a new strain of Streptomyces hygroscopicus.27 - O - 去甲基雷帕霉素，一种由新型吸水链霉菌菌株产生的免疫抑制化合物。

J Antibiot (Tokyo). 1995 Nov;48(11):1347-9. doi: 10.7164/antibiotics.48.1347.

7

SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.

Transplantation. 1997 Jul 15;64(1):32-5. doi: 10.1097/00007890-199707150-00007.

8

Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.雷帕霉素类似物的构效关系研究：C-7甲氧基是效应结构域的一部分且位于FKBP12-FRAP界面的证据。

Chem Biol. 1995 Jul;2(7):471-81. doi: 10.1016/1074-5521(95)90264-3.

9

Mechanism of action of rapamycin (Sirolimus, Rapamune).

Transplant Proc. 1996 Apr;28(2):964-9.

10

Rapamycin.雷帕霉素

Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S129.

引用本文的文献

1

Pharmacogenetics to optimize immunosuppressant therapy in systemic lupus erythematosus: a scoping review.药物遗传学优化系统性红斑狼疮免疫抑制治疗：一项范围综述

Pharmacogenomics. 2025 Feb-Mar;26(3-4):129-142. doi: 10.1080/14622416.2025.2490464. Epub 2025 Apr 10.

2

A novel rapalog shows improved safety vs. efficacy in a human organoid model of polycystic kidney disease.一种新型雷帕霉素类似物在多囊肾病的人体类器官模型中显示出更好的安全性与有效性。

Stem Cell Reports. 2025 Feb 11;20(2):102395. doi: 10.1016/j.stemcr.2024.102395. Epub 2025 Jan 23.

3

Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors.